@inproceedings{inproceedings, title  = {{A DNA plasmid melanoma cancer vaccine, SCIB1, combined with nivolumab plus ipilimumab in patients with advanced unresectable melanoma: Efficacy and safety results from the open-label phase 2 SCOPE trial}},

 url = {{}},

 year = {{2024}},

 month = {{1}},

 author = {{Shaw HM and Patel PM and Payne M and Kumar S and Danson S and Highley M and Prasad K and Board R and Barlow C and Larkin J and Young K et al}},

 volume = {{42}},

 journal = {{JOURNAL OF CLINICAL ONCOLOGY}},

 issue = {{16}},

 note = {{Accessed on 2024/12/26}}}